Bridgebio Pharma Inc (BBIO)

Operating Expenses

$335.71M

Quarterly · Period ending: · USD

BBIO logo

BBIO Operating Expenses

Latest reported$335.71M
BBIO Quarterly Operating Expenses ($41.84M → $335.71M)
High-resolution chart · PNG

BBIO operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bridgebio Pharma Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
335,709,000
290,046,000
324,000,000
259,336,000
241,190,000
218,366,000
229,825,000
193,884,000
177,109,000
210,179,000
178,563,000
161,185,000
147,141,000
127,338,000
130,455,000
128,715,000
153,222,000
174,024,000
176,949,000
150,389,000
147,930,000
167,966,000
127,611,000
128,066,000
124,567,000
102,487,000
92,457,000
78,773,000
69,318,000
63,752,000
65,583,000
41,456,000
34,783,000
41,838,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.